{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:55:33Z","timestamp":1789556133188,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To systematically review the use of diuretics to reduce postpartum hypertension among individuals with hypertensive disorders of pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE, CINAHL, and Cochrane Central Register of Controlled Trials were searched through June 2024 (PROSPERO CRD42021288277).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>Randomized controlled trials investigating postpartum diuretic use in individuals with hypertensive disorders of pregnancy with 20 or more participants per arm were included. Primary outcomes were hypertension within 2 weeks postpartum and mean systolic or diastolic blood pressure after treatment. Secondary postpartum outcomes included severe maternal morbidity, use of additional antihypertensives, readmission, hypertension at 6 weeks postpartum, and breastfeeding. Risk of bias was assessed with the Cochrane handbook. A random-effects meta-analysis model used the restricted maximum-likelihood estimated treatment effects with relative risk (RR)\/mean difference and 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>Of 469 records reviewed, 10 randomized controlled trials were included (1,815 individuals: 906 intervention, 909 control). Interventions included furosemide (five trials, N=958), torsemide (one trial, N=118), combined furosemide\u2013antihypertensive drug (three trials, N=670), and combined thiazide\u2013angiotensin-converting enzyme inhibitor (one trial, N=67). Seven trials were at high risk of bias. Diuretic use was associated with a reduction in hypertension within 2 weeks postpartum (five trials, N=1,055, pooled RR 0.54, 95% CI, 0.39\u20130.74; number needed to treat [NNT] 4). There was no difference in mean systolic or diastolic blood pressure after treatment with diuretics; there was also no difference in severe maternal morbidity, readmissions, or any other secondary outcomes. When analysis was restricted to trials at low risk of bias, the reduction in postpartum hypertension was not significant (two trials, N=502, RR 0.62, 95% CI, 0.36\u20131.09).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Diuretics were associated with a reduction in immediate postpartum hypertension in individuals with hypertensive disorders of pregnancy (NNT 4), although this reduction was not observed when analysis was restricted to trials at low risk of bias. Further studies are needed to assess the role of diuretics in treating postpartum hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n                    <jats:p>PROSPERO, CRD42021288277.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006032","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T21:00:26Z","timestamp":1755205226000},"page":"500-514","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Postpartum Diuretics for Hypertensive Disorders of Pregnancy"],"prefix":"10.1097","volume":"146","author":[{"given":"Emma","family":"Trawick Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Quist-Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana Jaffe","family":"Brotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneet P.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha M.","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Fishel Bartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"R1-20260825","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","article-title":"Hypertensive disorders in pregnancy and mortality at delivery hospitalization\u2014United States, 2017-2019","volume":"71","author":"Ford","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20260825","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/CIRCULATIONAHA.115.015721","article-title":"Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period","volume":"132","author":"Goel","year":"2015","journal-title":"Circulation"},{"key":"R3-20260825","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/AOG.0000000000005680","article-title":"Readmission rates after expedited postpartum discharge","volume":"144","author":"Walia","year":"2024","journal-title":"Obstet Gynecol"},{"key":"R4-20260825","doi-asserted-by":"crossref","first-page":"113.e1","DOI":"10.1016\/j.ajog.2016.01.174","article-title":"A multi-state analysis of postpartum readmissions in the United States","volume":"215","author":"Clapp","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20260825","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/AOG.0000000000002372","article-title":"Timing and risk factors of postpartum stroke","volume":"131","author":"Too","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R6-20260825","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1055\/s-0041-1739429","article-title":"Adverse outcomes during postpartum readmissions after deliveries complicated by hypertensive disorders of pregnancy","volume":"39","author":"Emeruwa","year":"2022","journal-title":"Am J Perinatol"},{"key":"R8-20260825","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13669-022-00343-6","article-title":"Best practices for managing postpartum hypertension","volume":"11","author":"Kumar","year":"2022","journal-title":"Curr Obstet Gynecol Rep"},{"key":"R9-20260825","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"Chronic hypertension in pregnancy. ACOG Practice Bulletin No. 203","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R10-20260825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.preghy.2022.11.009","article-title":"Blood pressure changes in gestational hypertension, preeclampsia, and chronic hypertension from preconception to 42-day postpartum","volume":"31","author":"Palatnik","year":"2023","journal-title":"Pregnancy Hypertens"},{"key":"R11-20260825","first-page":"CD004351","article-title":"Prevention and treatment of postpartum hypertension","author":"Magee","year":"2013","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R12-20260825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items For Systematic Review and Meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R13-20260825","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R15-20260825","doi-asserted-by":"crossref","first-page":"101614","DOI":"10.1016\/j.ajogmf.2025.101614","article-title":"Postpartum furosemide for accelerating recovery in patients with preeclampsia: a randomized placebo-controlled trial: furosemide for postpartum hypertension","volume":"7","author":"Cursino","year":"2025","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R16-20260825","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.AOG.0000148270.53433.66","article-title":"Postpartum preeclampsia management with furosemide: a randomized clinical trial","volume":"105","author":"Ascarelli","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R17-20260825","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3329\/bjms.v18i3.41640","article-title":"Efficacy of postpartum furosemide therapy on blood pressure recovery in patients with severe preeclampsia: a randomized clinical trial","volume":"18","author":"Dabaghi","year":"2019","journal-title":"Bangladesh J Med Sci"},{"key":"R18-20260825","doi-asserted-by":"crossref","first-page":"571.e1","DOI":"10.1016\/j.ajog.2023.01.015","article-title":"Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial","volume":"228","author":"Fishel Bartal","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20260825","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/HYPERTENSIONAHA.120.16133","article-title":"Furosemide for accelerated recovery of blood pressure postpartum in women with a hypertensive disorder of pregnancy: a randomized controlled trial","volume":"77","author":"Lopes Perdigao","year":"2021","journal-title":"Hypertension"},{"key":"R20-20260825","first-page":"482","article-title":"Furosemide versus hydralazine for managing post partum hypertension in severe preeclampsia: a comparative study","volume":"20","author":"Mahmoodabadi","year":"2012","journal-title":"J Shahid Sadoughi Univ Med Sci"},{"key":"R21-20260825","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4067\/S0717-75262019000200112","article-title":"Furosemida en el control de la hipertensi\u00f3n arterial posparto en preecl\u00e1mpticas severas","volume":"84","author":"Reyna-Villasmil","year":"2019","journal-title":"Rev Chil Obstet Ginecol"},{"key":"R22-20260825","first-page":"119","article-title":"Comparative study between oral labetalol vs oral labetalol with oral frusemide in control of blood pressure among postpartum mothers with severe pre-eclampsia","volume":"16","author":"Suganya","year":"2024","journal-title":"Int J Pharm Clin Res"},{"key":"R23-20260825","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/AOG.0000000000002941","article-title":"Torsemide for prevention of persistent postpartum hypertension in women with preeclampsia: a randomized controlled trial","volume":"132","author":"Viteri","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R24-20260825","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/10641955.2016.1239735","article-title":"Furosemide in postpartum management of severe preeclampsia: a randomized controlled trial","volume":"36","author":"Veena","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"R27-20260825","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/HJH.0000000000003310","article-title":"The use of loop diuretics in the context of hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"41","author":"Malham\u00e9","year":"2023","journal-title":"J Hypertens"},{"key":"R28-20260825","doi-asserted-by":"crossref","first-page":"e086208","DOI":"10.1136\/bmjopen-2024-086208","article-title":"Oral antihypertensive agents and diuretics in the management of hypertension in postpartum women: a systematic review and meta-analysis","volume":"14","author":"Hup","year":"2024","journal-title":"BMJ Open"},{"key":"R29-20260825","doi-asserted-by":"crossref","first-page":"100517","DOI":"10.1016\/j.ajogmf.2021.100517","article-title":"Postpartum management of hypertension and effect on readmission rates","volume":"4","author":"Lovgren","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R30-20260825","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"R31-20260825","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"R34-20260825","first-page":"308","article-title":"Breast milk and drugs","volume":"14","author":"Font","year":"1989","journal-title":"MCN Am J Maternal\/Child Nurs"},{"key":"R35-20260825","first-page":"251","article-title":"Suppression of postpartum lactation with furosemide","volume":"50","author":"Cominos","year":"1976","journal-title":"S Afr Med J"},{"key":"R36-20260825","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ajog.2024.04.016","article-title":"Lasix for the prevention of de novo postpartum hypertension: a randomized placebo-controlled trial (LAPP Trial)","volume":"232","author":"Emeruwa","year":"2024","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:00:31Z","timestamp":1787652031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006032"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006032","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"2025-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}